May 7, 2026 07:00AM
May 7, 2026 07:00AM
Apr 30, 2026 09:00AM
Mar 3, 2026 07:00AM
Mar 3, 2026 07:00AM
Feb 24, 2026 09:00AM
Dec 5, 2025 09:00AM Amylyx reports early safety data for ALS drug AMX0114
Dec 5, 2025 09:00AM
Nov 6, 2025 07:03AM
Nov 6, 2025 07:00AM
Oct 30, 2025 09:00AM
Oct 17, 2025 08:35AM
Oct 10, 2025 11:08AM
Oct 7, 2025 03:12PM Important Notice to Long-Term Shareholders of Amylyx Pharmaceuticals, Inc. (AMLX): Grabar Law Office is Investigating Claims on Your Behalf as Securities Fraud Class Action Survives Motion to Dismiss
Aug 7, 2025 07:00AM
Aug 7, 2025 07:00AM
Jul 31, 2025 09:00AM
Jul 13, 2025 05:00PM
Jul 8, 2025 07:00AM
Jun 3, 2025 07:01AM
Jun 3, 2025 07:00AM Amylyx Pharmaceuticals Receives U.S. FDA Fast Track Designation for AMX0114 for the Treatment of Amyotrophic Lateral Sclerosis
May 12, 2025 07:01AM
May 12, 2025 07:00AM
May 8, 2025 07:01AM
May 8, 2025 07:00AM
May 1, 2025 09:00AM
Apr 30, 2025 07:03AM
Apr 30, 2025 07:00AM Amylyx Pharmaceuticals Announces First Participant Dosed in Pivotal Phase 3 LUCIDITY Trial of Avexitide in Post-Bariatric Hypoglycemia
Apr 9, 2025 07:00AM
Mar 4, 2025 06:00AM
Mar 4, 2025 06:00AM
Feb 24, 2025 09:00AM
Jan 21, 2025 09:00AM
Jan 21, 2025 09:00AM
Jan 6, 2025 09:00AM Amylyx Pharmaceuticals Appoints Dan Monahan as Chief Commercial Officer
Dec 4, 2024 07:32AM
Dec 4, 2024 07:30AM
Nov 7, 2024 07:02AM
Nov 7, 2024 07:00AM
Nov 4, 2024 09:00AM
Aug 12, 2024 09:00AM
Aug 8, 2024 07:00AM Amylyx Pharmaceuticals, Inc. (AMLX) Misses Q2 EPS by 34c
Aug 8, 2024 07:00AM
Aug 5, 2024 09:00AM
May 9, 2024 07:01AM
May 9, 2024 07:00AM
May 2, 2024 09:00AM
Apr 3, 2024 09:00AM
Apr 1, 2024 11:30AM AMYLYX PHARMACEUTICALS, INC. (NASDAQ: AMLX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Amylyx
Mar 29, 2024 09:00PM

1,197,306 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All